Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | $5.20 | $5.83 | $5.52 |
| Q2 2026 | 2 | $5.34 | $5.45 | $5.39 |
| Q3 2026 | 1 | $5.84 | $5.97 | $5.90 |
| Q4 2026 | 1 | $7.13 | $7.28 | $7.20 |
| Q1 2027 | 1 | $6.17 | $6.31 | $6.24 |
| Q2 2027 | 1 | $6.16 | $6.29 | $6.22 |
| Q3 2027 | 1 | $6.33 | $6.47 | $6.40 |
| Q4 2027 | 1 | $7.49 | $7.65 | $7.57 |
Chemed Corp. last posted its earnings results on Wednesday, February 25th, 2026. The company reported $6.42 earnings per share for the quarter, missing analysts' consensus estimates of $7.02 by $0.6. The company had revenue of 639.34 M for the quarter and had revenue of 2.53 B for the year. Chemed Corp. has generated $18 earnings per share over the last year ($18.42 diluted earnings per share) and currently has a price-to-earnings ratio of 22.23. Chemed Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/27/2026 | Q4 2025 | N/A | $5.48 | N/A | $659.09 M | $639.34 M |
| 10/31/2025 | Q3 2025 | N/A | $4.46 | N/A | $626.04 M | $624.90 M |
| 07/31/2025 | Q2 2025 | N/A | $3.60 | N/A | $628.58 M | $618.80 M |
| 04/28/2025 | Q1 2025 | N/A | $4.91 | N/A | $641.78 M | $646.94 M |
| 04/01/2025 | Q4 2024 | N/A | $6.08 | N/A | $636.10 M | $639.99 M |
| 11/01/2024 | Q3 2024 | N/A | $5.04 | N/A | $612.22 M | $606.18 M |
| 07/26/2024 | Q2 2024 | N/A | $4.70 | N/A | $599.20 M | $595.88 M |
| 04/29/2024 | Q1 2024 | N/A | $4.30 | N/A | $591.46 M | $589.23 M |
| 02/29/2024 | Q4 2023 | N/A | $5.96 | N/A | N/A | $585.91 M |
| 10/27/2023 | Q3 2023 | N/A | $4.97 | N/A | N/A | $564.53 M |
| 07/28/2023 | Q2 2023 | N/A | $3.54 | N/A | N/A | $553.82 M |
| 04/28/2023 | Q1 2023 | N/A | $3.62 | N/A | N/A | $560.16 M |
| 02/27/2023 | Q4 2022 | N/A | $4.17 | N/A | N/A | $546.65 M |
| 11/02/2022 | Q3 2022 | N/A | $3.82 | N/A | N/A | $526.47 M |
| 07/29/2022 | Q2 2022 | N/A | $4.45 | N/A | N/A | $531.29 M |
| 04/29/2022 | Q1 2022 | N/A | $4.28 | N/A | N/A | $530.55 M |
| 02/28/2022 | Q4 2021 | N/A | $4.89 | N/A | N/A | $540.98 M |
| 11/01/2021 | Q3 2021 | N/A | $4.62 | N/A | N/A | $538.67 M |
| 07/30/2021 | Q2 2021 | N/A | $3.57 | N/A | N/A | $532.26 M |
| 04/30/2021 | Q1 2021 | N/A | $4.08 | N/A | N/A | $527.36 M |
The conference call for Chemed Corp.'s latest earnings report can be listened to online.
The conference call transcript for Chemed Corp.'s latest earnings report can be read online.
Chemed Corp. (:CHE) has a recorded annual revenue of $2.53 B.
Chemed Corp. (:CHE) has a recorded net income of $265.24 M.Chemed Corp. has generated $18.42 earnings per share over the last four quarters.
Chemed Corp. (:CHE) has a price-to-earnings ratio of 22.23 and price/earnings-to-growth ratio is -7.06.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED